跳至主要内容
临床试验/NCT03045562
NCT03045562Unknown4 期

Effects of Salvianolate Injection on Myocardial Microcirculation in Patients With Acute ST Segment Elevation Myocardial Infarction After Primary PCI

Green Valley Group of China1 个研究点 分布在 1 个国家目标入组 536 人开始时间: 2017年1月20日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
发起方
入组人数
536
试验地点
1
主要终点
TIMI flow grade

研究概览

简要总结

To evaluate the influence of Salvianolate injection on myocardial microcirculation perfusion in subjects with STEMI who underwent primary PCI

详细描述

This is a prospective, randomized, double-blind and controlled study.536 subjects of STEMI who underwent primary PCI within the first 12 hours will be enrolled.all patients were assigned to receive 300mg of asprin and ≥300mg of clopidogrel as loading dose,and following 100mg and 75mg once daily respectively.Patients were assigned to receive Salvianolate injection or 0.9% sodium chloride injection in catherter room setting,and following similar medicine once daily respectively for 7 days.Myocardial circulation perfusion will be checked with mmediate coronary angiography parameters,ECG,echocardiographic,CK-MB.The major adverse cardiovascular events will be observed.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Informed consent must be obtained prior to any study procedure.
  • •Age>18 years.
  • •Subjects of STEMI who underwent primary PCI within the first 12 hours.

排除标准

  • •Allergic to Salvianolate injection
  • •Mechanical complications
  • •History of severe renal or hepatic insufficiency
  • •Pregnant or breastfeeding women
  • •Pool compliance,greater risks result from the study

研究组 & 干预措施

Experimental group

Experimental

Patients will be assigned to receive Salvianolate injection dissolved in 100ml of normal saline

干预措施: Salvianolate injection (Drug)

Control group

Placebo Comparator

Patients will be assigned to receive 100ml of normal saline

干预措施: Normal saline (Drug)

结局指标

主要结局

TIMI flow grade

时间窗: an average of 2 hours

Use TIMI flow grade to evaluate myocardial circulation perfusion

TIMI myocardial perfusion grade

时间窗: an average of 2 hours

Use TIMI myocardial perfusion grade to evaluate myocardial circulation perfusion

次要结局

  • ST-segment resolution(up to 90 minutes)
  • myocardial contrast echocardiograph(up to 7 days)
  • creatine kinase isoenzyme(up to 48 hours)
  • major adverse cardiovascular events(an average of 30 days)

研究者

发起方
Green Valley Group of China
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验